The Fifth Hospital of Shijiazhuang Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2012
NCT01488526
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

The Fifth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China

Active Ingredients

Drugs in Phase 4 Trials (1)

tenofovir (viread) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Infections (Phase 4)

Viremia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1